Literature DB >> 15370619

Complete sustained regression of extensive psoriasis with cetuximab combination chemotherapy.

Florence Trivin, Eveline Boucher, Jean-Luc Raoul.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15370619     DOI： 10.1080/02841860410020211

Source DB:  PubMed          Journal:  Acta Oncol        ISSN： 0284-186X            Impact factor:   4.089


× No keyword cloud information.
  7 in total

1.  Cetuximab and panitumumab in a patient with colon cancer and concomitant chronic skin disease: a potential beneficial effect on psoriasis vulgaris.

Authors:  Ken Okamoto; Hiromichi Maeda; Takeo Shiga; Mai Shiga; Ken Dabanaka; Kazuhiro Hanazaki; Michiya Kobayashi
Journal:  World J Gastroenterol       Date:  2015-03-28       Impact factor: 5.742

Review 2.  Recent advances on the roles of epidermal growth factor receptor in psoriasis.

Authors:  Sijia Wang; Zhuoli Zhang; Han Peng; Kang Zeng
Journal:  Am J Transl Res       Date:  2019-02-15       Impact factor: 4.060

3.  A case of psoriasis pustolosa palmaris induced by cetuximab.

Authors:  Elena Marinello; Davide Pastorelli; Mauro Alaibac
Journal:  BMJ Case Rep       Date:  2016-03-18

4.  Keratinocyte but not endothelial cell-specific overexpression of Tie2 leads to the development of psoriasis.

Authors:  Julie A Wolfram; Doina Diaconu; Denise A Hatala; Jessica Rastegar; Dorothy A Knutsen; Abigail Lowther; David Askew; Anita C Gilliam; Thomas S McCormick; Nicole L Ward
Journal:  Am J Pathol       Date:  2009-04       Impact factor: 4.307

5.  Pharmacological control of receptor of advanced glycation end-products and its biological effects in psoriasis.

Authors:  A V Mezentsev; S A Bruskin; A G Soboleva; V V Sobolev; E S Piruzian
Journal:  Int J Biomed Sci       Date:  2013-09

6.  The EGFR-ERK/JNK-CCL20 Pathway in Scratched Keratinocytes May Underpin Koebnerization in Psoriasis Patients.

Authors:  Kazuhisa Furue; Takamichi Ito; Yuka Tanaka; Akiko Hashimoto-Hachiya; Masaki Takemura; Maho Murata; Makiko Kido-Nakahara; Gaku Tsuji; Takeshi Nakahara; Masutaka Furue
Journal:  Int J Mol Sci       Date:  2020-01-09       Impact factor: 5.923

7.  Cetuximab treatment in a patient with metastatic colorectal cancer and psoriasis.

Authors:  B Neyns; V Meert; F Vandenbroucke
Journal:  Curr Oncol       Date:  2008-08       Impact factor: 3.677
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.